AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This has with reference to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 kindly note that Mr. Adhish P. Patil, Chief Financial Officer of the Company had attended the conference 'THE AMSEC CONNECT-2' organised by Asian Markets Securities Pvt. Ltd. (AMSEC) on September 9, 2020. AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
This has with reference to Regulation 30(6) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 kindly note that Mr. Adhish P. Patil, Chief Financial Officer of the Company had attended 'Ashwamedh, Elara India Virtual Dialogue 2020' on 1st and 2nd September, 2020. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant Rule 22 of Companies (Management and Administration) Rules, 2014, other applicable provisions of the Companies Act, 2013 and SEBI Listing Regulations, we enclose the copies of newspaper advertisement published in Financial Express (English) and Apla Mahanagar (Marathi) regarding the Postal Ballot Notice AARTI DRUGS LTD. - 524348 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aarti Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Result of 35th Annual General Meeting AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting details of the proceedings of 35th Annual General Meeting (AGM) of the Company held on Tuesday, August 25, 2020 at 11:30 AM through Video Conferencing. Please find enclosed herewith the following disclosures pertaining to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: 1. Proceedings of the 35th AGM as Annexure A and 2. Disclosure under Schedule III of the Regulations as Annexure B (Appointment and Retirement of Director)
MC Insider: Aarti Drugs' blazing run, cues from a market veteran, beer trouble, mortgage moolah, a punchy exit and more
Hush-hush tales from the world of stock markets, banking, corporate world and corridors of power